Breaking News

Avenue Therapeutics Inc (ATXI)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

4.200 -0.310 -6.87%

07/05 - Closed. Currency in USD ( Disclaimer )

Pre Market

4.120

-0.080

-1.905%

11:15:12 - Real-time Data

Volume: 1,084,186
Bid/Ask: 0.000 / 0.000
Day's Range: 4.043 - 5.970

Type: Equity

Market: United States

Avenue Therapeutics Company Profile

Read the Avenue Therapeutics Inc company profile to learn more about the business and the management team. View Avenue Therapeutics Inc facts about employee data, company products and services, and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.

Contact Information

Address 1111 Kane Concourse Suite 301
Bay Harbor Islands, 33154
United States

Phone 781 652 4500

Fax -

Web www.avenuetx.com

Top Executives

Name	Age	Since	Title
Lindsay Allan Rosenwald	69	2015	Executive Director
Neil Herskowitz	67	2015	Non-Executive Independent Director
Alexandra MacLean	56	2022	CEO & Director
Jay D. Kranzler	65	2017	Chairman of the Board
Curtis G. Oltmans	61	2021	Independent Director
Faith L. Charles	-	2022	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

ATXI Price Commentary

Write your thoughts about Avenue Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

albert Garcia Blanco Jan 12, 2024 16:36

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Avenue Therapeutics, a New York-based biotechnology company, announced on January 12, 2024 that it plans to increase its workforce by 300% by the end of April 2024. The company is hiring to work on a number of new projects , including: A new treatment for lung cancer Avenue Therapeutics is developing a new treatment for lung cancer that uses a combination of immunotherapy and chemotherapy. The treatment is designed to attack cancer cells more effectively and reduce the side effects of chemotherapy. A new treatment for Alzheimer's disease Avenue Therapeutics is developing a new treatment for Alzheimer's disease that uses a combination of drugs and gene therapy. The treatment is designed to reduce the buildup of amyloid plaques in the brain, which is believed to be one of the causes of the disease. A new treatment for cystic fibrosis Avenue Therapeutics is developing a new treatment for cystic fibrosis that uses a combination of gene therapy and cell therapy. Treatment is designed to correct the genetic defect that causes the disease. These projects are unique in the world for their innovative approach to the treatment of serious diseases. If successful, they could have a significant impact on the health of patients around the world. In addition to these projects, Avenue Therapeutics is also developing new treatments for other diseases, such as multiple sclerosis, rheumatoid arthritis and diabetes. The company is committed to researching new therapies that can improve patients' lives.

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="233555684">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="233555684" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="233555684" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="233555684">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	8,341.85	+28.18	+0.34%
DAX	18,504.25	+65.72	+0.36%
Euro Stoxx 50	5,041.85	+25.75	+0.51%
S&P 500	5,187.70	+6.96	+0.13%
Nikkei 225	38,199.50	-597.00	-1.54%
Dow Jones	38,884.26	+31.99	+0.08%
FTSE 100 Futures	8,352.8	+9.4	+0.11%

Brent Oil	82.42	-0.74	-0.89%
Crude Oil WTI	77.66	-0.72	-0.92%
Gold	2,324.05	-0.15	-0.01%
Silver	27.473	-0.071	-0.26%
Copper	4.5370	-0.0685	-1.49%
London Cocoa	8,345.00	+346.00	+4.33%
London Wheat	185.40	+3.65	+2.01%

U.K. 10Y	4.1930	+0.0640	+1.55%
U.K. 5Y	4.0835	+0.0595	+1.48%
U.K. 2Y	4.3660	+0.0690	+1.61%
Germany 10Y	2.4585	+0.0375	+1.55%
U.S. 10Y	4.483	+0.024	+0.54%
U.S. 5Y	4.497	+0.026	+0.59%
U.S. 2Y	4.843	+0.015	+0.31%

Lloyds Banking	53.70	-0.02	-0.04%
Vodafone Group PLC	67.080	-0.840	-1.24%
Barclays	211.30	+0.95	+0.45%
BT Group	104.23	-1.22	-1.16%
HSBC	720.30	+7.70	+1.08%
BHP Group Ltd	2,276.69	-17.31	-0.75%
Exxon Mobil	116.22	-0.53	-0.45%

Recent Quotes

	Name	Price	Chg.	Chg. %
	ATXI	4.200	-0.310	-6.87%

Market Movers

Name	Last	Chg. %	Vol.
BP	497.80	-1.17%	14.52M
HSBC	720.40	+1.10%	12.17M
Glencore	460.92	-1.50%	8.24M
BAE Systems	1,390.50	+1.27%	3.44M
Shell	2,895.8	+0.03%	1.87M
AstraZeneca	12,298.0	+1.49%	705.89K
Rio Tinto PLC	5,521.0	-1.25%	689.58K

Name	Last	Chg. %	Vol.
MFE MEDIAFOREUROPE NV B	3.766	+211.50%	4.31K
Mobile Tornado	2.70	+184.21%	10.23M
SAF Holland	16.84	+151.34%	1.20K
Frontline	270.00	+138.31%	11.00K
Guerbet	37.40	+127.77%	0.02K
Idex ASA	1.9504	+110.17%	2.19K
Saipem	2.13	+97.22%	2.95M

Name	Last	Chg. %	Vol.
Casino Guichard	0.0318	-97.31%	92.22K
Wirecard	0.0192	-97.20%	0.24K
ams OSRAM AG	1.20	-94.17%	28.26K
H Lundbeck B	34.08	-80.38%	0.67K
BioGaia B	124.90	-75.77%	4.19K
SAAB B	231.45	-73.60%	2.67K
Oxford Cannabinoid Technologies Holdings	0.10	-71.43%	102.58M